192 related articles for article (PubMed ID: 1711947)
41. Monoclonal antibody to type IV collagen with selective basement membrane localization.
Scheinman JI; Tsai C
Lab Invest; 1984 Jan; 50(1):101-12. PubMed ID: 6363814
[TBL] [Abstract][Full Text] [Related]
42. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays.
Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH
Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504
[TBL] [Abstract][Full Text] [Related]
43. Isolation and characterization of mouse glomerular basement membrane.
Baelde HJ; Bergijk EC; Bruijn JA
J Clin Lab Immunol; 1990 Sep; 33(1):17-20. PubMed ID: 1966940
[TBL] [Abstract][Full Text] [Related]
44. A monoclonal antibody marker for Alport syndrome identifies the Alport antigen as the alpha 5 chain of type IV collagen.
Ding J; Kashtan CE; Fan WW; Kleppel MM; Sun MJ; Kalluri R; Neilson EG; Michael AF
Kidney Int; 1994 May; 45(5):1504-6. PubMed ID: 8072264
[TBL] [Abstract][Full Text] [Related]
45. Production of monoclonal antibodies to fibronectin, type IV collagen and other antigens of the human glomerulus.
Hancock WW; Kraft N; Clarke F; Atkins RC
Pathology; 1984 Apr; 16(2):197-206. PubMed ID: 6205356
[TBL] [Abstract][Full Text] [Related]
46. Evidence for separate networks of classical and novel basement membrane collagen. Characterization of alpha 3(IV)-alport antigen heterodimer.
Kleppel MM; Fan W; Cheong HI; Michael AF
J Biol Chem; 1992 Feb; 267(6):4137-42. PubMed ID: 1740456
[TBL] [Abstract][Full Text] [Related]
47. Production and characterization of a monoclonal antibody to human Type IV collagen.
Sakai LY; Engvall E; Hollister DW; Burgeson RE
Am J Pathol; 1982 Sep; 108(3):310-8. PubMed ID: 6287846
[TBL] [Abstract][Full Text] [Related]
48. Comparison of non-collagenous type IV collagen subunits in human glomerular basement membrane, alveolar basement membrane, and placenta.
Shen GQ; Butkowski R; Cheng T; Wieslander J; Katz A; Cass J; Fish AJ
Connect Tissue Res; 1990; 24(3-4):289-301. PubMed ID: 2376130
[TBL] [Abstract][Full Text] [Related]
49. Heterogeneity of antibodies in Goodpasture syndrome reacting with type IV collagen.
Kefalides NA; Ohno N; Wilson CB
Kidney Int; 1993 Jan; 43(1):85-93. PubMed ID: 7679459
[TBL] [Abstract][Full Text] [Related]
50. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V
J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167
[TBL] [Abstract][Full Text] [Related]
51. Immunogold studies of monomeric elements from the globular domain (NC1) of type IV collagen in renal basement membranes during experimental diabetes in the rat.
Desjardins M; Gros F; Wieslander J; Gubler MC; Bendayan M
Diabetologia; 1990 Nov; 33(11):661-70. PubMed ID: 2150195
[TBL] [Abstract][Full Text] [Related]
52. Antigen restriction and IgG subclasses among anti-GBM autoantibodies.
Segelmark M; Butkowski R; Wieslander J
Nephrol Dial Transplant; 1990; 5(12):991-6. PubMed ID: 2128958
[TBL] [Abstract][Full Text] [Related]
53. Characterization of a non-Goodpasture autoantibody to type IV collagen.
Johansson C; Butkowski R; Swedenborg P; Alm P; Wieslander J
Nephrol Dial Transplant; 1993; 8(11):1205-10. PubMed ID: 8302456
[TBL] [Abstract][Full Text] [Related]
54. Semiquantitative analysis of the effects of fixation and paraffin embedding on immunoreactivity of renal basement membranes to a monoclonal antibody against type IV collagen.
Yoshida T; Adachi E; Matsubara O; Kino J; Asamatsu C; Sato Y; Nakajima K; Fukushima S; Hayashi T
Arch Histol Cytol; 1992 Dec; 55(5):497-502. PubMed ID: 1295548
[TBL] [Abstract][Full Text] [Related]
55. Production of anti-NC1 antibody by affected male dogs with X-linked hereditary nephritis: a probe for assessing the NC1 domain of collagen type IV in dogs and humans with hereditary nephritis.
Thorner PS; Baumal R; Valli VE; Mahuran D; Marrano PM; Jacobs R
Virchows Arch A Pathol Anat Histopathol; 1992; 421(6):467-75. PubMed ID: 1466151
[TBL] [Abstract][Full Text] [Related]
56. Epitope mapping of anti-glomerular basement membrane (GBM) antibodies with synthetic peptides.
Hellmark T; Brunmark C; Trojnar J; Wieslander J
Clin Exp Immunol; 1996 Sep; 105(3):504-10. PubMed ID: 8809141
[TBL] [Abstract][Full Text] [Related]
57. The involvement of type IV collagen in Goodpasture's syndrome.
Wieslander J; Heinegård D
Ann N Y Acad Sci; 1985; 460():363-74. PubMed ID: 3868956
[TBL] [Abstract][Full Text] [Related]
58. Development and application of an ELISA for Goodpasture's disease based on sheep alpha 3(IV)NC1 domains.
Katbamna I; Turner N; Ross CN; Pusey CD
J Clin Lab Immunol; 1995; 47(1):11-24. PubMed ID: 8735432
[TBL] [Abstract][Full Text] [Related]
59. Globular domain of basement membrane collagen induces autoimmune pulmonary lesions in mice resembling human Goodpasture disease.
Wick G; Von der Mark H; Dietrich H; Timpl R
Lab Invest; 1986 Sep; 55(3):308-17. PubMed ID: 3528661
[TBL] [Abstract][Full Text] [Related]
60. Methods in laboratory investigation. Monoclonal antibodies to type IV collagen: probes for the study of structure and function of basement membranes.
Foellmer HG; Madri JA; Furthmayr H
Lab Invest; 1983 May; 48(5):639-49. PubMed ID: 6682465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
